Document is current
Any future updates will be listed below
-
Authors
Modi, Rakesh N. https://orcid.org/0000-0001-9651-6690
Massou, Efthalia
Charlton, Peter H.
Dymond, Andrew
Williams, Kate
Brimicombe, James
Freedman, Ben
Griffin, Simon J.
Hobbs, F. D. Richard
Lip, Gregory Y. H.
McManus, Richard J.
Mant, Jonathan
-
Funding
Funding for this research was provided by:
National Institute for Health and Care Research (RP-PG-0217-20007)
National Institute for Health and Care Research (RP-PG-0217-20007)
National Institute for Health and Care Research (RP-PG-0217-20007)
National Institute for Health and Care Research (RP-PG-0217-20007)
National Institute for Health and Care Research (RP-PG-0217-20007)
National Institute for Health and Care Research (RP-PG-0217-20007)
National Institute for Health and Care Research (RP-PG-0217-20007)
Wellcome Trust (203921/Z/16/Z)
British Heart Foundation (FS/20/20/34626)
NSW Health
National Institute for Health and Care Research Applied Research Collaboration Oxford and Thames Valley
NIHR Oxford Biomedical Research Centre
Horizon 2020 (899871)
- License Information
-
More Information
Article History
Received: 25 July 2024
Accepted: 6 May 2025
First Online: 26 May 2025
Declarations
:
: This feasibility study received ethical approval from the London – Central NHS Research Ethics Committee (19/LO/1597). Written informed consent to participate was obtained from all participants in the study. The research was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: All authors are undertaking the SAFER study named in the paper. JM has performed consultancy work for BMS/Pfizer and Omron. FDRH reports occasional consultancy for BMS/Pfizer, Bayer and BI over the last five years. GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos. No fees are received personally. SJG has received honoraria from Astra Zeneca for lecturer at postgraduate educational meetings for primary care teams about type 2 diabetes. BF has received speaker fees, honoraria, and non-financial support from the BMS and Pfizer Alliance; and loan devices for investigator initiated studies from Alivecor: all were unrelated to the present study, but related to screening for AF. PHC has performed consultancy work for Cambridge University Technical Services and has received honoraria from IOP Publishing and Emory University (the latter not received personally).
